By Jasmin Boyce ( October 28, 2022, 7:18 PM EDT) -- AbbVie has slapped rival drugmakers including Sandoz and Teva with a patent suit in Delaware federal court over its brand-name endometriosis medication Orilissa, arguing that the accused rivals are jumping the gun on a generic version of the high-earning treatment....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.